Accuray announced the launch of its Synchrony motion tracking and correction technology to be used with the Radixact System. This new feature adds intrafraction motion synchronization capabilities to the Radixact System, enabling real-time tracking, visualization and correction for tumor motion during treatment, with the goal of improving dose accuracy and treatment times compared to conventional radiation therapy systems. The Radixact System with Synchrony will be unveiled at the European Society for Radiotherapy & Oncology (ESTRO) meeting, April 26-30 in Milan, Italy.


Wires have traditionally been placed prior to lumpectomy to mark cancerous tissues in the breast. Wire-free localizers, however, provide alternatives. And their clinical applications may expand.


Non-small cell lung cancer is a common cancer for both men and women. Many people who are diagnosed with this type of cancer are not candidates for surgery due to heart disease from a history of tobacco use. For these patients who cannot have a surgery, stereotactic body radiation therapy (SBRT) or stereotactic ablative radiotherapy (SABR) is a safe, effective and convenient treatment. Over the years, several published dose guidelines for this radiation treatment have been used by physicians. But a common dose schedule has not previously existed.

Konica Minolta Healthcare Americas Inc. announced that its Dynamic Digital Radiography (DDR) technology, introduced at the 2018 Radiological Society of North America (RSNA) annual meeting, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The company says DDR represents the next evolution in X-ray imaging with the ability to capture movement in a single exam and is a fundamental change in the way clinicians can utilize radiography.


Signs of what the future may look like in women’s health dotted the exhibit floor of the Society for Breast Imaging (SBI)/American College of Radiology (ACR) Breast Imaging Symposium in Hollywood, Fla. Notable was an emphasis on productivity.


April 22, 2019 — Mentice AB, provider of endovascular performance solutions, has signed an agreement with the nonprofit public service RAD-AID to donate high-fidelity simulators for interventional radiology (IR) procedure training in various resource-constrained regions of the world. Under the agreement, Mentice pledges to contribute simulator software, hardware and expertise to RAD-AID IR educational teams.

The Medicare Hospital Insurance (HI) Trust Fund, which funds Medicare Part A, will only be able to pay full benefits for Medicare beneficiaries until 2026, according to the 2019 annual report from the Medicare Board of Trustees. The Supplementary Medical Insurance (SMI) Trust Fund, which funds Medicare Part B and D, is expected to be adequately financed in all years, but the aging population and rising healthcare costs are projected to grow SMI costs from 2.1 percent of gross domestic product (GDP) in 2018 to approximately 3.7 percent of GDP in 2038.

April 22, 2019 — A new study finds wide state-by-state variations in Medicaid reimbursements to physicians who treat cancer patients with radiation therapies. These differences could compound existing disparities in access to healthcare in rural communities, which tend to have higher Medicaid coverage rates than metropolitan areas.


Artificial intelligence (AI) may powerfully influence women’s health.


Ching-Jen Chen, M.D., of the neurosurgery department at the University of Virginia (UVA) Health System, was the winner of the Cerebrovascular Section Best Clinical Scientific Paper at the 2019 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting, April 13-17 in San Diego. Chen’s research investigated stereotactic radiosurgery for pediatric versus adult brain arteriovenous malformations (AVM). The aim of this international, multicenter, retrospective, matched-cohort study is to directly compare the outcomes after stereotactic radiosurgery (SRS) for brain AVM in pediatric versus adult patients.

Subscribe Now